We are live on ! Find out more
SAM

Simplify Asset Management Portfolio holdings

AUM $7.19B
1-Year Est. Return 6.88%
This Fund
S&P 500
This Quarter Est. Return
-0.64%
1 Year Est. Return
+6.88%
3 Year Est. Return
+44.98%
5 Year Est. Return
+50.08%
10 Year Est. Return
–
AUM
$2.02B
AUM Growth
-$122M
Cap. Flow
-$78.6M
Cap. Flow %
-3.88%
Top 10 Hldgs %
86.93%
Holding
129
New
23
Increased
19
Reduced
34
Closed
37

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$144M
2
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$89.6M
3
ARQT icon
Arcutis Biotherapeutics
ARQT
+$8.13M
4
DXCM icon
DexCom
DXCM
+$7.8M
5
RMD icon
ResMed
RMD
+$7.26M

Top Sells

Rank Stock Value
1
MTBA icon
Simplify MBS ETF
MTBA
+$55.3M
2
SCHP icon
Schwab US TIPS ETF
SCHP
+$38.1M
3
JPST icon
JPMorgan Ultra-Short Income ETF
JPST
+$25M
4
SRPT icon
Sarepta Therapeutics
SRPT
+$19.6M
5
ZTS icon
Zoetis
ZTS
+$11.7M

Sector Composition

Rank Sector Weight
1 Healthcare 7.7%
2 Energy 1.16%
3 Industrials 0.75%
4 Consumer Discretionary 0.38%
5 Real Estate 0.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SNY icon
51
Sanofi
SNY
$107B
$1.95M 0.1%
40,387
-163,756
-80% -$8.33M
RITM icon
52
Rithm Capital
RITM
$5.2B
$1.9M 0.09%
175,780
+40,980
+30% +$444K
VRTX icon
53
Vertex Pharmaceuticals
VRTX
$123B
$1.89M 0.09%
+4,689
New +$2.17M
RVTY icon
54
Revvity
RVTY
$12.3B
$1.78M 0.09%
15,920
-8,383
-34% -$985K
ITCI
55
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$1.69M 0.08%
20,268
-10,615
-34% -$872K
WUSA
56
DELISTED
Simplify Wolfe US Equity 150/50 ETF
WUSA
$1.56M 0.08%
+59,800
New +$1.54M
ALHC icon
57
Alignment Healthcare
ALHC
$4.26B
$1.49M 0.07%
+132,774
New +$1.55M
NLY icon
58
Annaly Capital Management
NLY
$16.9B
$1.47M 0.07%
80,274
-43,028
-35% -$841K
COO icon
59
Cooper Companies
COO
$14B
$1.45M 0.07%
15,793
+6,925
+78% +$705K
INSM icon
60
Insmed
INSM
$23.5B
$1.42M 0.07%
+20,520
New +$1.48M
AGNC icon
61
AGNC Investment
AGNC
$12.9B
$1.32M 0.07%
143,550
+11,550
+9% +$113K
KYMR icon
62
Kymera Therapeutics
KYMR
$9.52B
$1.23M 0.06%
30,515
– –
ZVRA icon
63
Zevra Therapeutics
ZVRA
$755M
$1M 0.05%
120,000
– –
ARGX icon
64
argenx
ARGX
$53.8B
$991K 0.05%
1,611
-808
-33% -$473K
BNTC icon
65
Benitec Biopharma
BNTC
$439M
$964K 0.05%
76,337
-40,198
-34% -$434K
SPQ
66
DELISTED
Simplify US Equity PLUS QIS ETF
SPQ
$913K 0.05%
33,592
-5,626
-14% -$176K
LONA
67
LeonaBio Inc
LONA
$67.8M
$876K 0.04%
149,279
– –
TSLR icon
68
GraniteShares 2x Long TSLA Daily ETF
TSLR
$79.9M
$818K 0.04%
+18,909
New +$582K
ACHV icon
69
Achieve Life Sciences
ACHV
$644M
$767K 0.04%
217,845
– –
NXTI icon
70
Simplify Next Intangible Core Index ETF
NXTI
$40.2M
$757K 0.04%
26,999
-4,522
-14% -$133K
PMT
71
PennyMac Mortgage Investment
PMT
$863M
$725K 0.04%
57,600
+47,600
+476% +$644K
CAH icon
72
Cardinal Health
CAH
$53.5B
$718K 0.04%
+6,101
New +$712K
PCRX icon
73
Pacira BioSciences
PCRX
$1.01B
$711K 0.04%
+37,742
New +$663K
RARE icon
74
Ultragenyx Pharmaceutical
RARE
$2.88B
$707K 0.03%
+16,810
New +$834K
KURA icon
75
Kura Oncology
KURA
$964M
$697K 0.03%
80,000
– –
1 2
3
4 5

Similar funds

CFG
Citizens Financial Group Providence, Rhode Island $7.19B AUM 23.93% 1-Year Est. Return
FPP
Findlay Park Partners London, United Kingdom $7.17B AUM 17.27% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
UB
UMB Bank Kansas City, Missouri $7.16B AUM 20.88% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
FPA
First Pacific Advisors El Segundo, California $7.14B AUM 21.51% 1-Year Est. Return
SC
Saturna Capital Bellingham, Washington $7.13B AUM 35.47% 1-Year Est. Return
MNA
Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return

Simplify Asset Management's Q4 2024 Portfolio in Review

As of Q4 2024, Simplify Asset Management held 129 positions worth $2.02B, down 5.7% from $2.15B the previous quarter. Its ten largest holdings account for 87% of the portfolio.

Simplify Asset Management withdrew a net $78.6M in Q4 2024, closing 37 positions and reducing 34 holdings. Its most notable exit was Simplify MBS ETF, an estimated $55.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 7.7% of assets, down from 12% a quarter earlier, followed by Energy and Industrials.

Against the trend, Simplify Asset Management opened a new position in Arcutis Biotherapeutics worth $10.3M.

  • Simplify Asset Management's largest Q4 2024 buy was Arcutis Biotherapeutics: 742,299 shares worth $10.3M.
  • Simplify Asset Management added most to iShares Core S&P 500 ETF in Q4 2024, an estimated $144M increase.
  • Simplify Asset Management's biggest Q4 2024 reduction was Sarepta Therapeutics, cutting an estimated $19.6M.
  • Simplify Asset Management fully exited Simplify MBS ETF in Q4 2024, selling an estimated $55.3M.
  • Simplify Asset Management's ten largest holdings make up 87% of its $2.02B portfolio in Q4 2024.
  • Simplify Asset Management opened 23 new positions and closed 37 in Q4 2024.
  • Simplify Asset Management's portfolio value fell 5.7% quarter-over-quarter to $2.02B.

Based on Simplify Asset Management's 13F filing for Q4 2024, filed 11 Feb 2025.